ARGXLARGE

argenx SE

HealthcareBiotechnology
$807.55
$0.13(+1.62%)
52W$510.06
$934.62
Updated May 7, 12:00 AM
RSI54
RS Rating54/99
Beta0.52
Volatility31%
F-Score3/9
Mkt Cap$50.0B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

argenx SE is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 54), indicating performance broadly in line with the market. Earnings growth of 13% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
54
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.52
vs S&P 500
DEFENSIVE
52W Position
70%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$757.07
50 SMA > 100 SMA$795.36
100 SMA > 150 SMA$815.83
150 SMA > 200 SMA$783.91

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$803.53+0.50%ABOVE
50 SMA$757.07+6.67%ABOVE
100 SMA$795.36+1.53%ABOVE
150 SMA$815.83-1.01%BELOW
200 SMA$783.91+3.02%ABOVE

Price Performance

1D+1.6%
1W+4.1%
1M+7.9%
3M-0.5%
6M-5.1%
YTD-3.9%
1Y+31.3%
3Y+25.8%
52-Week Trading Range70% from low
$807.55
52W Low$510.06
52W High$934.62

Technical Indicators

RSI (14)NEUTRAL
53.7
305070
VCP ScoreWARM
7/10
Base depth: 23.6%

Risk Profile

Beta
0.52
52W Vol
31%
ATR
$19.42
Max DD (1Y)
-29%

Volume Analysis

Today
413.8K
50D Avg
327.1K
Vol Ratio
1.26x
Liquidity
LIQUID

Earnings Momentum

Q4'23+63%
$-2.95
Q2'24+93%
$-0.55
Q4'24+364%
$12.20
Q2'25+414%
$6.37
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+85.39%
5 Years:+94.61%
3 Years:+63.92%
TTM:+335.20%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+167.07%

Stock Price CAGR

10 Years:+42.74%
5 Years:+25.61%
3 Years:+25.76%
1 Year:+31.29%

Return on Equity

10Y Avg:-20.4%
5Y Avg:-15.9%
3Y Avg:-5.9%
Last Year:15.1%

Key Metrics

Market Cap$50.0B
Gross Margin89.6%
Net Margin38.0%
Piotroski F-Score3/9

Frequently Asked Questions

Is ARGX in an uptrend right now?

ARGX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is ARGX overbought or oversold?

ARGX's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.

Is ARGX outperforming the market?

ARGX has a Relative Strength (RS) Rating of 54 out of 99. ARGX is performing about average compared to the market.

Where is ARGX in its 52-week range?

ARGX is trading at $807.55, which is 86% of its 52-week high ($934.62) and 70% above its 52-week low ($510.06).

How volatile is ARGX?

ARGX has a Beta of 0.52 and 52-week volatility of 31%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.